Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Circulation Research|November 2, 2002
Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell deathOrlando F Bueno, Jeffery D Molkentin
Molecular and Cellular Biology|May 30, 2003
Altered skeletal muscle phenotypes in calcineurin Aalpha and Abeta gene-targeted miceStephanie A Parsons, Benjamin J Wilkins, Orlando F Bueno, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2002
Defective T cell development and function in calcineurin A beta -deficient miceOrlando F Bueno, Eric B Brandt, Marc E Rothenberg, et al.
The Journal of Cell Biology|February 28, 2002
PKC alpha regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase1/2 (ERK1/2)Julian C Braz, Orlando F Bueno, Leon J De Windt, et al.
Advances in Therapy|September 29, 2018
Effect of Azithromycin on Venetoclax Pharmacokinetics in Healthy Volunteers: Implications for Dosing Venetoclax with P-gp InhibitorsSuresh K Agarwal, Bo Tong, Orlando F Bueno, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 14, 2017
Clinical evaluation of P-glycoprotein inhibition by venetoclax: a drug interaction study with digoxinManoj S Chiney, Rajeev M Menon, Orlando F Bueno, et al.
The EMBO Journal|October 1, 2003
c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signalingQiangrong Liang, Orlando F Bueno, Benjamin J Wilkins, et al.
Molecular and Cellular Biology|January 20, 2004
Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytesNicole H Purcell, Dina Darwis, Orlando F Bueno, et al.
Cardiovascular Research|April 2, 2002
Calcineurin and hypertrophic heart disease: novel insights and remaining questionsOrlando F Bueno, Eva van Rooij, Jeffery D Molkentin, et al.
Pageof 4